Manufacturer

newflavours srl: which brands it is named as making

Named in a government registerCompany registry record169 linked brands

On the public record, not assessed

newflavours srl is in this dataset because a government authority published a record naming it against 169 notified brands. Everything on this page is read out of that record. Nothing has been assessed: no production licence, export licence, capacity figure, patent or court record has been checked for this company, so the fields listed as uncollected below are gaps in collection, not findings.

Record fetched 11 October 2026. No assessment date, because no assessment has been run.

What the register states

Each row is a value published by the authority named at the foot of this page. Nothing here is derived.

Company name as notified: newflavours srl
Other spellings in this register: newflavours · newflavours srl

Brands notified against this company

Each row is a notified brand whose filing names this company. The confidence level says whether the authority stated the manufacturing role or whether it published one field for two roles.

1886 2 ml 12 mg/ml podConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
1886 2 ml 9 mg/ml podConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
1886 9 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
1886 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
ALMA 18 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
ALMA 9 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
BANANITA 18 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
BANANITA 9 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
BLU BLOOD 18 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
BLUE BLOOD 9 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
BRASIL 10 ml 12 mg/mlConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
BRASIL 10 ml 9 mg/mlConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
BRASIL 2 ml 12 mg/ml podConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
BRASIL 2 ml 9 mg/ml podConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
BURBERO 18 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
BURBERO 9 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
CARAMEL 18 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
COCCO NUT 18 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
COCCO NUT 9 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
COFFE BREAK 18 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
CONCEPT VAPURE 18 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
CONCEPT VAPURE 9 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
CUBA 10 ml 12 mg/mlConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
CUBA 10 ml 9 mg/mlConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
CUBA 2 ml 12 mg/ml podConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
CUBA 2 ml 9 mg/ml podConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
DARK CHOC 18 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
DARK CHOC 9 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
DRINK 18 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
DRINK 9 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
FLUIDAConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
FRUIT MIX 18 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
FRUIT MIX 9 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
GOLD FIRE 18 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
GREEN ONE 18 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
GREEN ONE 9 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HACCOCIBLA 18 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HACCOCIBLA 9 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HAVANA 18 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HAVANA 9 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HIT 18 mg/mlConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HIT 2 ml 12 mg/mlConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HIT 2 ml 12 mg/ml podConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HIT 2 ml 14 mg/mlConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HIT 2 ml 15 mg/mlConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HIT 2 ml 16 mg/mlConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HIT 2 ml 17 mg/mlConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HIT 2 ml 19 mg/mlConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HIT 2 ml 1mg/mlConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HIT 2 ml 20 mg/mlConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HIT 2 ml 2mg/mlConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HIT 2 ml 3mg/mlConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HIT 2 ml 5 mg/mlConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HIT 2 ml 6 mg/mlConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HIT 2 ML 7 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HIT 2 ML 8 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HIT 9 mg/mlConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HOTCIGAR 18 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
HOTCIGAR 9 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.
ICE 18 MG/MLConfirmed
notified 2026-10-11
Why we think this
The reasoning, in the words the record supports
Stated in a notification published by FOD Volksgezondheid / SPF Santé publique (Belgium) under Directive 2014/40/EU Art. 20(8), fetched 11 October 2026. Recorded as confirmed: the authority states the manufacturer separately from the company that filed the notification, and a second national register names the same company independently, placing it outside the European Economic Area where it cannot be the EU-side importer. It is evidence of a supply relationship for the notified product, not of exclusivity.
Records behind it
No source record is attached to this link, so the sentence above is the inference and nothing stands under it yet.

Showing the first 60 of 169. 169 of the 169 are stated outright by an authority rather than inferred from a field that carries two roles at once.

Not collected yet

Each row is a check Traceleaf has not run for this company. Uncollected is not the same as zero, and not the same as nothing found.

Chinese-language company name: placeholder — not collected
Unified social credit code: placeholder — not collected
City and province: placeholder — not collected
Year founded: placeholder — not collected
Registered capital: placeholder — not collected
STMA production licence: placeholder — not collected
Export licence: placeholder — not collected
Declared annual capacity: placeholder — not collected
Product lines and coil technology: placeholder — not collected
Patents: placeholder — not collected
Litigation: placeholder — not collected
Certifications: placeholder — not collected
Headcount: placeholder — not collected

Records

The authority that published the record, and the instrument that obliges it to. The register's own title, its endpoint and the field each value was read out of are operational detail and are not published.

FOD Volksgezondheid / SPF Santé publique (Belgium)
Published under Directive 2014/40/EU Art. 20(8). Fetched 11 October 2026.

A notification is a statement the notifying company made to that authority on that date, published because the instrument above requires it. It is evidence of what was declared, not a finding by Traceleaf and not an endorsement by the authority.

This is a demonstration build. There is no billing, no checkout and no account, and the locked sections above are rendered from the same dataset as the free ones and are obscured to show where the line would fall.

Looking for a factory we don’t cover?

Name it and we will trace it next. Every miss is demand data: the factorys people search for and we cannot answer are what decides the order we build coverage in.